<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02154568</url>
  </required_header>
  <id_info>
    <org_study_id>16885</org_study_id>
    <secondary_id>W81XWH-09-2-0027</secondary_id>
    <nct_id>NCT02154568</nct_id>
  </id_info>
  <brief_title>Study of Airflow in the Lungs Using Helium MRI</brief_title>
  <official_title>Flow Quantification in the Human Airways Using Hyperpolarized Helium 3 MRI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Virginia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Computer simulations are being developed to predict air flow abnormalities in the airways of&#xD;
      patients with lung disease. The purpose of this study is to obtain actual gas flow&#xD;
      measurements in the lungs of healthy patients and patients with lung disease and use these&#xD;
      measurements to validate the computer models.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Biotechnology High Performance Computing Software Applications Institute (BHSAI) of the&#xD;
      Department of Defense (DoD) is studying airflow in the lungs using computational fluid&#xD;
      dynamics in order to characterize disease-specific airflow patterns and provide useful&#xD;
      information for medical applications. To validate these models, they are seeking to obtain&#xD;
      experimental data of airflow in human lungs, both healthy and diseased. An assessment of&#xD;
      airflow can be obtained by using hyperpolarized noble gas (HNG) magnetic resonance imaging&#xD;
      (MRI) or, more specifically, hyperpolarized helium-3 (HHe) MRI in conjunction with&#xD;
      flow-encoding schemes that are well-established in conventional proton MRI&#xD;
&#xD;
      Four chronic obstructive pulmonary disease (COPD) patients and four healthy subjects will&#xD;
      undergo pulmonary function tests (PFTs), computed tomography (CT) scan covering the mouth,&#xD;
      neck, and chest, and hyperpolarized helium 3 MRI. Before and after the MRI scans, three&#xD;
      spirometry readings will be taken while the subject is lying in the same position as in the&#xD;
      MR scanners. Data will be analyzed by the BHSAI. UVa will provide the de-identified raw image&#xD;
      data and the de-identified results of the spirometry and other tests to BHSAI&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">July 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hyperpolarized helium MRI flow velocity map</measure>
    <time_frame>Day 1</time_frame>
    <description>Using hyperpolarized helium as an inhaled contrast agent for MRI, we will measure the velocity of inhaled breath in the trachea.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Spirometry (FEV1)</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spirometry (FVC)</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>COPD</condition>
  <condition>Healthy</condition>
  <condition>Constrictive Bronchitis</condition>
  <arm_group>
    <arm_group_label>Hyperpolarized helium MRI of the chest</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>hyperpolarized helium MRI of the chest</intervention_name>
    <description>Using hyperpolarized helium as an inhaled gaseous contrast agent for MRI, we will measure the velocity of inhaled breath in the trachea.</description>
    <arm_group_label>Hyperpolarized helium MRI of the chest</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy subjects:&#xD;
&#xD;
               -  Normal PFT values: FEV1 &gt; 90% predicted; and Forced vital capacity (FVC) &gt; 90%&#xD;
                  predicted&#xD;
&#xD;
               -  Normal chest x-ray (CXR)&#xD;
&#xD;
               -  Medical history: No active pulmonary symptoms (cough, shortness of breath,&#xD;
                  sputum); Negative history of pulmonary disease; Negative smoking history (never&#xD;
                  smoked)&#xD;
&#xD;
          -  Pulmonary Disease Subjects:&#xD;
&#xD;
               -  PFT values: FEV1/FVC &lt; 70% (indicative of obstruction); and 30% &lt; FEV1 &lt; 50%&#xD;
                  predicted&#xD;
&#xD;
               -  CXR normal except hyperinflation&#xD;
&#xD;
               -  Symptoms - chronic shortness of breath&#xD;
&#xD;
          -  All test subjects, healthy and with COPD should have similar physical anthropometric&#xD;
             characteristics:&#xD;
&#xD;
               -  Similar age with age difference less than 3 years&#xD;
&#xD;
               -  Similar height (within 3-4 inches)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any condition for which a MRI procedure is contraindicated.&#xD;
&#xD;
          -  Presence of any non-MRI compatible metallic material in the body, such as pacemakers,&#xD;
             metallic clips, etc.&#xD;
&#xD;
          -  Likelihood of claustrophobia&#xD;
&#xD;
          -  Chest circumference greater than that of the helium MR coil.&#xD;
&#xD;
          -  Pregnancy, by report of subject. Clinically in the Department of radiology at UVA,&#xD;
             self report is used when screening patients for MR scans as well as CT scans and&#xD;
             fluoroscopy studies. If the subject reports there is any chance of their being&#xD;
             pregnant a urine pregnancy test will be performed prior to any imaging.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rachel Dieterich, RN</last_name>
    <phone>434-243-6074</phone>
    <email>rrd8w@virginia.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie D Burdick</last_name>
    <phone>434-243-7363</phone>
    <email>mdb5b@virginia.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Virginia Health System</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Dieterich, RN</last_name>
      <phone>434-243-6074</phone>
      <email>rrd8w@virginia.edu</email>
    </contact>
    <contact_backup>
      <last_name>Marie D Burdick</last_name>
      <phone>434-243-7363</phone>
      <email>mdb5b@virginia.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Mike Shim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>May 30, 2014</study_first_submitted>
  <study_first_submitted_qc>May 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2014</study_first_posted>
  <last_update_submitted>November 2, 2020</last_update_submitted>
  <last_update_submitted_qc>November 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Virginia</investigator_affiliation>
    <investigator_full_name>Y. Michael Shim, MD</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Hyperpolarized gas MRI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

